NEW YORK (GenomeWeb News) — Clinical Data said today that underwriters in a public offering that closed yesterday have exercised an over-allotment option to buy an additional 450,000 shares of the company’s common stock.
 
Clinical Data, which announced the shelf registration on July 9, said it expects to bring in aggregate net proceeds of $71.5 million after issuing the total 3.45 million shares in the offering.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.